Scope of drug public advertising to be trimmed.

The scope of drug public advertising ban seems to define to the prescription drugs and raw materials instead of the former ban on the therapeutic groups.

The new provision permits a public advertising for the drugs to treat a new epidemic syndrome, recurrent epidemic diseases or an overseas epidemic disease that might infect to Korea.

The KFDA announced to disclose the draft of "Revise...